13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 52 holding rows worth $305,864,042.
- Accession
- 0001420506-24-000335
- Filer
- CIK 1595851
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 52 entries on the cover page, a total value of $305,864,042 stated on the cover page (in dollars after the unit check, H1), rows summing to $305,864,042 with VALUE read as dollars as filed, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 464287655 | SHS | 250,000 | $50,177,500 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $26,787,000 | dollars as filed | put |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 250,000 | $22,322,500 | dollars as filed | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 250,000 | $15,097,500 | dollars as filed | call |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 165,000 | $13,132,350 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 275,000 | $11,770,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 100,000 | $9,643,000 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 475,000 | $6,764,000 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 600,000 | $6,738,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 80,000 | $6,679,200 | dollars as filed | call |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 300,000 | $6,534,000 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 50,000 | $6,203,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 150,000 | $6,114,000 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 300,000 | $6,075,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 100,000 | $5,986,000 | dollars as filed | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 15,000 | $5,706,450 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 27,500 | $5,263,775 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 125,000 | $5,046,250 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 80,000 | $4,831,200 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 210,000 | $4,752,300 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 112,385 | $4,523,496 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 70,000 | $4,396,000 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 250,000 | $4,270,000 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 165,000 | $3,813,150 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,100,000 | $3,717,000 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 225,000 | $3,629,250 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 750,000 | $3,525,000 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 385,241 | $3,517,250 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 15,000 | $3,470,700 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 150,000 | $3,405,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 400,000 | $3,372,000 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 375,000 | $3,296,250 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 200,000 | $2,944,000 | dollars as filed | call |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 125,000 | $2,866,250 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 335,000 | $2,572,800 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 20,000 | $2,519,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 59,250 | $2,438,730 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 65,000 | $2,312,700 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 725,000 | $2,247,500 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 35,000 | $2,192,400 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 75,000 | $2,151,000 | dollars as filed | put |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 90,000 | $2,125,800 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 130,036 | $1,592,941 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 50,000 | $1,565,500 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 135,000 | $1,467,450 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 35,000 | $1,330,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 195,000 | $1,146,600 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 165,000 | $1,117,050 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 10,000 | $834,900 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V104 | COM | 1,600,000 | $643,200 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 465,000 | $641,700 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 30,000 | $596,400 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000335 | this filing | 2024-02-14 | acceptance time not in the bulk data set |